Folate Receptor Alpha Targeted Topiosomerase 1 CDC For Platinum Resistant Ovarian Cancer

Time: 5:00 pm
day: day 2- pm


  • Overviewing novel targeted CDot Conjugates for the treatment of Folate Receptor Alpha over-expressing tumors
  • Reviewing how CDC multivalent tumor targeting and high payload loading allows for the more effective killing of tumors with lower target antigen expression
  • Exploring how Elucida’s CDC can be expanded into other FR+/Topo1 responsive indications